Skip to main content
Home
OUR XCHANGES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
ANTIBODY MANUFACTURING
CNS DISCOVERY
OLIGONUCLEOTIDES & PEPTIDES
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
MUNICH, EU
PAST EVENTS
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY DRUG CONJUGATES THERAPEUTICS
ANTIBODY MANUFACTURING
ANTIBODY THERAPEUTICS
CNS DISCOVERY
IMMUNOTHERAPIES
MEDTECH STRATEGY
OLIGONUCLEOTIDES & PEPTIDES
NEWS XCHANGE
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
MEDIA PARTNERS
ABOUT US
GET TO KNOW US
FAQS
MEET THE TEAM
GALLERY
CONTACT US
Home
OUR XCHANGES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
ANTIBODY MANUFACTURING
CNS DISCOVERY
OLIGONUCLEOTIDES & PEPTIDES
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
MUNICH, EU
PAST EVENTS
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY DRUG CONJUGATES THERAPEUTICS
ANTIBODY MANUFACTURING
ANTIBODY THERAPEUTICS
CNS DISCOVERY
IMMUNOTHERAPIES
MEDTECH STRATEGY
OLIGONUCLEOTIDES & PEPTIDES
NEWS XCHANGE
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
MEDIA PARTNERS
ABOUT US
GET TO KNOW US
FAQS
MEET THE TEAM
GALLERY
CONTACT US
Sponsorship Enquiry
Register For Free
Home
OUR XCHANGES
BY TOPIC
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY THERAPEUTICS
ANTIBODY MANUFACTURING
CNS DISCOVERY
OLIGONUCLEOTIDES & PEPTIDES
BY LOCATION
BOSTON, USA
SAN FRANCISCO, USA
MUNICH, EU
PAST EVENTS
INDUSTRY EXPERTS
ADVANCED THERAPIES
AI IN DRUG DISCOVERY
ANTIBODY DRUG CONJUGATES THERAPEUTICS
ANTIBODY MANUFACTURING
ANTIBODY THERAPEUTICS
CNS DISCOVERY
IMMUNOTHERAPIES
MEDTECH STRATEGY
OLIGONUCLEOTIDES & PEPTIDES
NEWS XCHANGE
PARTNERSHIPS
OUR PARTNERS
BECOME A PARTNER
MEDIA PARTNERS
ABOUT US
GET TO KNOW US
FAQS
MEET THE TEAM
GALLERY
CONTACT US
Advanced Therapies Xchange - Boston - 2026
Loading
Next-gen delivery methods – in vivo vs. ex vivo approaches for autologous and allogeneic therapies
04 May 2026
15:40 - 16:40
Next Gen Vector Engineering & Delivery
Add to Calendar
LinkedIn
YouTube
Search
Search
Search
Username *
Password *
Login
